Inside information: Faron Presents Phase 1 Data from BEXMAB

Inside information: Faron Presents Phase 1 Data from BEXMAB in Myeloid Malignancies Trial at the 65th American Society of Hematology (ASH) Annual Meeting

Inside information: Faron Presents Phase 1 Data from BEXMAB in Myeloid Malignancies Trial at the 65th American Society of Hematology (ASH) Annual Meeting

tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Texas , United States , Helsinki , Eteläuomen Läi , Finland , San Diego Convention Center , California , San Diego , Boston , Massachusetts , Jukka , Lapland , American , Lindsey Neville , Sandy Jamieson , Mika Kontro , Mary Jane Elliott , Jo Turner , Markku Jalkanen , Christopher Golden , Juha Karttunen , David Daley , American Society Of Hematology , Faron Pharmaceuticals Ltd , Helsinki University Hospital , University Of Texas Md Anderson Cancer Center , University Of Helsinki , Peel Hunt , Cairn Financial Advisers , Company Announcement , Faron Presents Phase , Myeloid Malignancies Trial , American Society , Response Rate , First North , Annual Meeting , Chief Executive Officer , Naval Daver , Cancer Center , Principal Investigator , Efficacy Observed , Assess Safety , Myeloid Leukemias , Investigational Therapies , Excluding Transplantation , Diego Convention Center , Jane Elliott , Certified Adviser , Nasdaq First ,